US Patent Issued to Poseida Therapeutics on Feb. 3 for "Compositions and methods for the treatment of metabolic liver disorders" (California Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,335, issued on Feb. 3, was assigned to Poseida Therapeutics Inc. (San Diego).

"Compositions and methods for the treatment of metabolic liver disorders" was invented by Jingjing Jiang (San Diego), Julian Down (San Diego), Xianghong Li (San Diego) and Eric M. Ostertag (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to compositions and methods for the treatment of Metabolic Liver Disorders. The compositions and methods can comprise an adeno-associated virus (AAV) piggyBac polynucleotide comprising a transgene. The transgene may comprise ornithine transcarbamylase (OTC) or methylmalonyl-CoA mutase (MUT1)."

Th...